Novel sphingolipids and a process thereto
CA 2200267 A1 · Owner: Moreau, Robert Arthur · Inventors: Ross, Ronald Jr.; Moreau, Robert Arthur; Young, David Hamilton
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A process for novel sphingolipids and other secondary sphingosine-based compounds is provided which comprises the culturing of an appropriate fungus harvesting mycelium from the fungus and isolating the sphingolipid from the mycelium. The sphingosine-based materials inhibit protein kinase C provide an, anti-inflammatory effect or provide an anti-tumor effect; furthermore these, sphingosine-based materials provide protection for plants against pathogenic microorganisms.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 18, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 18, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 18, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.